Simple understanding and optimistic strategy for coping with atopic diseases

International Archives of Allergy and Immunology

Volumn 117, Issue 1, 1998, Pages 11-19

  Okudaira, Hirokazu ^a   Mori, Akio ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Atopic disease; CD4+ T cells; Eosinophilic inflammation; Interleukin 5; Transcription inhibitor

Indexed keywords

CYCLOSPORIN A; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 5; NONACTIN; TACROLIMUS;

ATOPY; EOSINOPHIL; HUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; EOSINOPHILS; HUMANS; HYPERSENSITIVITY, IMMEDIATE; INFLAMMATION; INTERLEUKIN-5;

EID: 0031663231     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000023985     Document Type: Review

References (96)

1. Coca AF, Cooke RA: On the classification of the phenomena of hypersensitiveness. J Immunol 1923;8:163-182.
2. Marsh DG, Meyers DA, Bias WB: The epidemiology and genetics of atopic allergy. N Engl J Med 1981;305:1551-1559.
3. Young RP, Sharp PA, Lynch JR, Faux JA, Lathrop GM, Cookson WO, Hopkin JM: Confirmation of genetic linkage between atopic IgE responses and chromosome 11q13. J Med Genet 1992;29:236-238.
4. Marsh DG, Neely JD, Breazeale DR, Ghosh B, Freidhoff LR, Ehrlich Kautzky E, Schou C, Krishnaswamy G, Beaty TH: Linkage analysis of IL-4 and other chromosome 5q31.1 markers and total serum IgE concentrations. Science 1994;264:1152-1156.
5. Daniels SE, Bhattacharrya S, James A, Leaves NI, Young A, Hill MR, Faux JA, Ryan GF, le-Souef PN, Lathrop GM: A genome-wide search for quantitatie trait loci underlying asthma. Nature 1996;383:247-250.
6. Godfrey RC: Asthma and IgE levels in urban and rural communities of The Gambia. Clin Allergy 1975;5:201-207.
7. Anderson HR: Respiratory abnormalities in Papua New Guinea children: The effects of locality and domestic wood smoke. Int J Epidemiol 1978;7:63-72.
8. Van Niekerk CH, Weinberg EG, Shore SC, Heese HV, Van Schalkwyk DJ: Prevalence of asthma: A comparative study of urban and rural Xhosa children. Clin Allergy 1979;9:319-324.
9. Waite DA, Eyles EF, Tarkin SL, O'Donnell TV: Asthma prevalence in Tokelnan children in two environments. Clin Allergy 1980;10: 71-75.
10. Prausnitz C, Küstner H: Studien über die Überempfindlichkeit. Zbl Bakt I. Abt. Originale 1921;86:160-169.
11. Ishizaka K, Ishizaka T, Hornbrook MM: Physicochemical properties of reaginic antibody. J Immunol 1966;97:840-853.
12. Dohi N, Okudaidra N, Sugiyama H, Tsurumachi K, Suko M, Nakagawa T, Monta Y, Ito K, Nakayama H, Miyamoto T: Bronchial responsiveness to mite allergen in atopic dermatitis without asthma. Int Arch Allergy Appl Immunol 1990;92:138-142.
13. Reed CE: Asthma, otherwise known as chronic desquamating eosinophilic bronchitis. Triangle 1988;27:61-66.
14. Dunnill MS: in Middleton E, Reed CE, Ellis EF (eds): Allergy Principles and Practice. St Louis, Mosby, 1978, p 678.
15. Gleich GJ, Motojima S, Frigas E, Kephart GM, Fujisawa T, Kravis LP: The eosinophilic leukocyte and the pathology of fatal bronchial asthma: Evidence for pathologic heterogeneity. J Allergy Clin Immunol 1987;80:412-415.
16. Laitinen LA, Heino M, Laitinen A, Kava T, Haahtela T: Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis 1985;131:599-606.
17. Wardlaw AJ, Dunnette S, Gleich GJ, Collins JV, Kay AB: Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Am Rev Respir Dis 1988;137:62-69.
18. Corrigan CJ, Kay AB: T cells and eosinophils in the pathogenesis of asthma. Immunol Today 1992;13:501-506.
19. Frew AJ, Durham SR, Kay AB: Inflammatory cell infiltration in late-phase asthmatic reaction; in Melillo G, Norman PS, Marone G (eds): Respiratory Allergy. Toronto, BC Decker, 1990, pp 31-36.
20. Jeffery PK, Waldlaw AJ, Nelson FC, Collins JV, Kay AB: Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989;140:1745-1753.
21. Hamid Q, Barkans J, Robinson DS, Durham SR, Kay AB: Co-expression of CD25 and CD3 in atopic allergy and asthma. Immunology 1992;75:659-663.
22. Bradley BL, Azzawi M, Jacobson M, Assoufi B, Collins JV, Irani AM, Schwartz LB, Durham SR, Jeffery P, Kay AB: Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: Comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol 1991;88:661-674.
23. Fabbri LM, Danieli D, Crescioli S, Bevilacqua P, Meli S, Saetta M, Mapp CE: Fatal asthma in a subject sensitized to toluene diisocyanate. Am Rev Respir Dis 1988;137:1494-1498.
24. Bentley AM, Maestrelli P, Saetta M, Fabbri LM, Robinson DS, Bradley BL, Jeffery PK, Durham SR, Kay AB: Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma. J Allergy Clin Immunol 1992;89:821-829.
25. Bentley AM, Menz G, Storz C, Robinson DS, Bradley B, Jeffery PK, Durham SR, Kay AB: Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Relationship to symptoms and bronchial responsiveness. Am Rev Respir Dis 1992;146:500-506.
26. Dent LA, Strath M, Mellor AL, Sanderson CJ: Eosinophilia in transgenic mice expressing interleukin 5. J Exp Med 1990;172:1425-1431.
27. Sehmi R, Wardlaw AJ, Cromwell O, Kurihara K, Waltmann P, Kay AB: Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. Blood 1992;79:2952-2959.
28. Walsh GM, Hartnell A, Waldlaw AJ, Kurihara K, Sanderson CJ, Kay AB: IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner. Immunology 1990;71: 258-265.
29. Booij-Noord H, De Vries K, Sluiter HJ, Orie NG: Late bronchial obstruction reaction to experimental inhalation of house dust extract. Clin Allergy 1972;2:43-61.
30. Durham SR, Kay AB: Eosinophils, bronchial hyperreactivity and late phase asthmatic reactions. Clin Allergy 1985;15:411-418.
31. Gerblich AA, Campbell A, Schuyler M: Changes in T lymphocyte subpopulations after antigenic bronchial provocation in asthmatics. N Engl J Med 1984;310:1349-1352.
32. De Monchy JG, Kauffman HF, Venge P, Koeter GH, Jansen HM, Sluiter HJ, De Vries K: Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 1985;131:373-376.
33. Diaz P, Gonzalez MC, Galleguillos FR, Ancic P, Cromwell O, Shepherd D, Durham SR, Gleich GJ, Kay AB: Leukocytes and mediators in bronchoalveolar lavage during allergen-induced late-phase asthmatic reactions. Am Rev Respir Dis 1989;139:1383-1389.
34. Metzger WJ, Zavala D, Richerson HB, Moseley P, Iwamota P, Monick M, Sjoerdsma K, Hunninghake GW: Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs. Am Rev Respir Dis 1987; 135:433-440.
35. Okudaira H, Mori A, Mikami T, Kaminuma O, Ohmura T, Hoshino A, Suko M: Selective suppression of IL-5 synthesis by OM-01 - pinpoint treatment of atopic diseases by IL-5 gene transcription inhibitor. Int Arch Allergy Immunol 1997;113:331-334.
36. Gleich GJ, Adolphson CR: The eosinophilic leukocyte: Structure and function. Adv Immunol 1986;39:177-253.
37. Kay AB: 'Helper' (CD4+) T cells and eosinophils in allergy and asthma. Am Rev Respir Dis 1992;145:S22-S26.
38. Hamid QM, Azzawi M, Ying S, Moqbel R, Wardlaw AJ, Corrigen CJ, Bradley B, Durham SR, Collins JV, Jeffery PK, Quint J, Kay AB: Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 1991;87:1541-1546.
39. Yamaguchi Y, Hayashi Y, Sugama Y, Miura T, Kasaharu S, Kitamura M, Torisu S, Mita A: Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. II-5 as an eosinophil chemotactic factor. J Exp Med 1988;167:1737-1742.
40. Walker C, Bode E, Boer L, Hansel TT, Blaser K, Virchow JC Jr: Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 1992;146:109-115.
41. Schumacher JH, O'Garra A, Shrader B, van Kimmenade A, Bond MW, Mosmann TR, Coffman RL: The characterization of four monoclonal antibodies specific for mouse IL-5 and development of mouse and human IL-5 enzyme-linked immunosorbent assay. J Immunol 1988;141:1576-1581.
42. Okudaira H, Nogami M, Matsuzaki G, Dohi M, Suko M, Kasuya S, Takatsu K: T-cell-dependent accumulation of eosinophils in the lung and its inhibition by monoclonal anti-interleukin-5. Int Arch Allergy Appl Immunol 1991;94:171-173.
43. Okudaira H, Miyamoto T: Interleukin-5 (IL-5) dependent accumulation of eosinophils in the lung. Allergy Clin Immunol News 1991;3: 117-121.
44. Lopez AF, To LB, Yang YC, Gambel JR, Shannon MF, Burns GF, Dyson PG, Juttner CA, Clark S, Vadas MA: Stimulation of proliferation, differentiation, and function of human cells by primate interleukin 3. Proc Natl Acad Sci USA 1987;84:2761-2765.
45. Metcalf D, Begley CG, Johnson GR, Nicola NA, Vadas MA, Lopez AF, Williamson DJ, Wong GG, Clark SC, Wang EA: Biologic properties in vitro of a recombinant human granulocyte macrophage colony-stimulating factor. Blood 1986;67:37-45.
46. Coeffier E, Joseph D, Vargaftig BB: LTB4, a potent chemotactic factor for purified guineapig eosinophils: Interference of PAF-acether antagonists. Int J Immunopharmacol 1991;13: 273-280.
47. Wardlaw AJ, Moqbel R, Cromwell O, and Kay AB: Platelet activating factor: A potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest 1986;78:1701-1706.
48. Nakajima H, Iwamoto I, Tomoe S, Matsumura R, Tomioka H, Takatsu K, Yoshida S: CD4+ T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. Am Rev Respir Dis 1992;146: 374-377.
49. Gulbenkian AR, Egan RW, Fernandez X, Jones H, Kreutner W, Kung T, Payvandi F, Sullivan L, Zurcher JA, Watnick AS: Interleukin-5 modulates eosinophil accumulation in allergic guinea pig lung. Am Rev Respir Dis 1992;146: 263-266.
50. Chand N, Harrison JE, Rooney S, Pillar J, Jakubicki R, Nolan K, Diamantis W, Sofia RD: Anti-IL-5 monoclonal antibody inhibits allergic late phase bronchial eosinophilia in guinea pigs: A therapeutic approach. Eur J Pharmacol 1992;211:121-123.
51. Mauser PJ, Pitman A, Witt A, Fernandez X, Zurcher J, Kung T, Jones H, Watnick AS, Egan RW, Kreutner W, and Adams GK: Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma. Am Rev Respir Dis 1993;148:1623-1627.
52. Nagai H, Yamaguchi S, Inagaki N, Tsuruoka N, Hitoshi Y, Takatsu K: Effect of anti-IL-5 monoclonal antibody on allergic bronchial eosinophilia and airway hyperresponsiveness in mice. Life Sci 1993;53:PL243-PL247.
53. Huang SK, Krishnaswamy G, Suz SN, Marsh DG, Liu M: Analysis of cytokine transcripts in the bronchoalveolar lavage cells of patients with asthma (abstract). J Immunol 1993;150: 138A.
54. Corrigan CJ, Haczku A, Gemou-Engesaeth V, Doi S, Kikuchi Y, Takatsu K, Durham SR, Kay AB: CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5. Effect of glucocorticoid therapy. Am Rev Respir Dis 1993;147:540-547.
55. Anderson GP, Coyle AJ: TH2 and 'TH2-like' cells in allergy and asthma: Pharmacological perspectives. Trends Pharmacol Sci 1994;15: 324-332.
56. Mori A, Suko M, Nishizaki Y, Kaminuma O, Kobayashi S, Matsuzaki G, Yamamoto K, Ito K, Tsuruoka N, Okudaira H: Interleukin-5 production by CD4+ T cells of asthmatic patients is suppressed by glucocorticoids and the immunosuppressants FK506 and cyclosporin A. Int Immunol 1995;7:449-457.
57. Mori A, Suko M, Nishizaki Y, Kaminuma O, Kobayashi S, Matsuzaki G, Ito K, Etoh T, Nakagawa H, Tsuruoka N, Okudaira H: Regulation of interleukin-5 production by peripheral blood mononuclear cells from atopic patients with FK506, cyclosporin A and glucocorticoid. Int Arch Allergy Immunol 1994;104(suppl 1): 32-35.
58. Takatsu K, Tominaga A, Harada N, Mita S, Matsumoto M, Takahashi T, Kukuchi Y, and Yamaguchi N: T cell-replacing factor (TRF)/interleukin-5 (IL-5); molecular and functional properties. Immunol Rev 1988;102:107-135.
59. Sanderson CJ, Cambell HD, Young IG: Molecular and cellular biology of eosinophil differentiation factor (interleukin-5) and its effects of human and mouse B cells. Immunol Rev 1988;102:29-50.
60. Okayama Y, Petit Frère C, Kassel O, Semper A, Quint D, Tunon de Lara MJ, Bradding P, Holgate ST, and Church MK: IgE-dependent expression of mRNA for IL-4 and IL-5 in human lung mast cells. J Immunol 1995;155: 1796-1808.
61. Bradding P, Feather IH, Wilson S, Bardin PG, Heusser CH, Holgate ST, and Howarth PH: Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. J Immunol 1993;151:3853-3865.
62. Broide DH, Paine MM, Firestein GS: Eosino-phils express interleukin-5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics J Clin Invest 1992;90:1414-1424.
63. Galli SJ: Mast cell-leukocyte cytokine cascade in allergy and inflammation. Allergy Clin Immunol News 1994;6:126-127.
64. Bradding P, Roberts JA, Britten KM, Montefort S, Djukanovic R, Mueller R, Heusser CH, Howarth PH, Holgate ST: Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: Evidence for the tuman mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994;10:471-180.
65. Martin TR, Takeishi T, Katz HR, Austen KF, Drazen JM, and Galli SJ: Mast cell activation enhances airway responsiveness to methacholine in the mouse. J Clin Invest 1993;91: 1176-1182.
66. Gordon JR, Galli SJ: Release of both performed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/cachectin by mouse mast cells stimulated via the Fc epsilon RI. A mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses. J Exp Med 1991;174: 103-107.
67. Nogami M, Suko M, Okudaira H, Miyamoto T, Shiga J, Ito M, Kasuya S: Experimental pulmonary eosinophilia in mice by Ascaris suum extract. Am Rev Respir Dis 1990;141:1289-1295.
68. Okudaira H, Mori A, Suko M, Ito K, Eoth T, Nakagawa H, Tsuruoka N (eds): Treatment of Atopic Diseases with Glucocorticoids, Cyclosporin A, and FK506: Anti-inflammatory Effects and inhibition of IL-5 Gene Transcription. Prog Allergy Clin Immunol. Stockholm, Hogrefc & Huber Publishers, 1995, vol 3, pp 310-315.
69. Okudaira H, Mori A, Suko M, Etoh T, Nakagawa H, Ito K: Enhanced production and gene expression of IL-5 in bronchial asthma - Management of atopic diseases with agents that downregulate IL-5 gene transcription. Allergy Clin Immunol News 1994;6:19-25.
70. Okudaira H, Mori A, Suko M, Etoh T, Nakagawa H, Ito K: Enhanced production and gene expression of IL-5 in patients with bronchial asthma: Possible management of atopic diseases by downregulation of IL-5 gene transcription. Int Arch Allergy Immunol 1995;107: 255-258.
71. Mori A, Suko M, Tsuruoka N, Eton T, Nakagawa H, Kaminuma O, Itoh K, Okudaira H: Atopic diseases and eosinophilic inflammation - possible management with agents which downregulate IL-5 gene transcription. Environ Dermatol 1994;1:42-54.
72. Mori A, Suko M, Nishizaki Y, Kaminuma O, Kobayashi S, Matsuzaki G, Yamamoto K, Ito K, Turuoka N, Okudaira H: IL-5 production by CD4+ T cells of asthmatic patients is suppressed by glucocorticoids and the immunosuppressants FK506 and cyclosporin A. Int Immunol 1995;7:449-457.
73. De Monchy JG, Kauffman HF, Venge P, Koeter GH, Jansen HM, Sluiter HJ, De Vries K: Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 1985;131:373-376.
74. Frew AJ, Moqbel R, Azzawi M, Hartnell A, Barkans J, Jeffery PK, Kay AB, Scheper RJ, Varley J, Church MK, Holgate ST: T lymphocytes and eosinophils in allergen-induced latephase asthmatic reactions in the guinea pig. Am Rev Respir Dis 1990;141:407-413.
75. Holgate ST, Hardy C, Robinson C, Agius RM, Howarth PH: The mast cell as a primary effector cell in the pathogenesis of asthma. J Allergy Clin Immunol 1986;77:274-282.
76. Brusselle GG, Kips JC, Tavernier JH, van der Heyden JG, Cuvelier CA, Pauwels RA, Bluetmann H: Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin Exp Allergy 1994;24:73-80.
77. Takeda K, Hamelmann E, Joetham A, Shultz LD, Larsen GL, Irvin CG, Gelfand EW: Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice. J Exp Med 1997;186:449-454.
78. Nakajima H, Iwamoto I, Tomoe S, Matsumura R, Tomioka H, Takatsu K, Yoshida S: CD4+ T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. Am Rev Respir Dis 1992;146: 374-377.
79. Gavett SH, Chen X, Finkelman F, Wills-Karp M: Depletion of murine CD4+ T lymphocytes-prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am J Respir Cell Mol Biol 1994;10:587-593.
80. Kaminuma O, Mori A, Ogawa K, Naito K, Nakata A, Kikkawa H, Suko M, Okudaira H: Successful transfer of late-phase eosinophil infiltration in the lung by infusion of helper T cell clones. Am J Respir Cell Mol Biol 1997; 16:448-454.
81. Kaminuma O, Mori A, Suko M, Kikkaawa H, Naito K, Okudaira H: Development of lung eosinophilic inflammation by the infusion of IL-5-producing T cell clones. Int Arch Allergy Immunol 1997;114(suppl 1):10-13.
82. Hogan SP, Mould A, Kikutani H, Ramsay AJ, Foster PS: Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins. J Clin Invest. 1997;99:1329-1339.
83. Lee JJ, McGarry MP, Farmer SC, Denzler KL, Larson KA, Carrigan PE, Brenneise IE, Horton MA, Kaczku A, Gelfand EW, Leikauf GD, Lee NA: Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med 1997;185:2143-2156.
84. Kita H, Weiler DA, Abu-Ghazaleh R, Sanderson CJ, Gleich GJ: Release of granule proteins from eosinophils cultured with IL-5. J Immunol 1992;149:629-635.
85. Mori A, Suko M, Kaminuma O, Nishizaki Y, Mikami T, Ohmura T, Hoshino A, Inoue S, Tsuruoka N, Okumura T, Sato G, Ito K, Okudaira H: A critical role of IL-2 for the production and gene transcription of IL-5 in allergen-specific human T cell clones. Int Immunol 1996;8:1889-1895.
86. Nakagawa H, Etoh T, Ishibashi Y, Higaki Y, Kawashima M, Torii H, Harada S: Tacrolimus ointment for atopic dermatitis (letter). Lancet 1994;344:883.
87. Arai K, Lee G, Miyajima A, Miyatake S, Arai N, Yokota T: Cytokines: Coordinators of immune and inflammatory responses. Annu Rev Biochem 1990;59:783-836.
88. Durand DB, Morgan MR, Wiss A, Crabtree GR: A 275 hase pair fragment at the 5′ end of the interleukin 2 gene enhances expression from a heterologous promoter in response to signals from the T cell antigen receptor. J Exp Med 1987;165:395-407.
89. Riegel JS, Corthesy B, Flanagan WM, Crabtree GR: Regulation of the interleukin-2 gene. Chem Immunol 1992;51:266-298.
90. Sigal NH, Dumont FJ: Cyclosporin A. FK506 and rapamycin: Pharmacologic probes of lymphocyte signal transduction. Annu Rev Immunol 1992;10:519-560.
91. Schreiber SL, Crabtree GR: The mechanism of action of cyclosporin A and FK506. Immunol Today 1992;13:136-141.
92. Vacca A, Felli MP, Farina AR, Martinotti S, Maroder M, Screpanti I, Meco D, Petrangeli E, Frait L, Gulino A: Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements. J Exp Med 1992;175:637-646.
93. Weinberger C, Hollenberg SM, Ong ES, Harmon JM, Brower ST, Cidlowski J, Thomson EB. Rosenfeld NG, Evans RH: Identification of human glucocorticoid receptor complementary DNA clones by epitope selection. Science 1985;228:740-742.
94. Leiferman KM, Ackerman SJ, Sampson HA, Haugen HS, Venecie PY, Gleich GJ: Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis. N Engl J Med 1985;312:282-285.
95. Bruijnzeel PL, Bruijnzeel-Kooman CA: Skin eosinophilia in atopic dermatitis. Allerg Immunol (Paris) 1989;21:224-227.
96. Paganelli R, Fanales-Belasio E, Carmini D, Scala E, Meglio P, Businco L, Aiuti F: Serum cosinophil cationic protein in patients with atopic dermatits. Int Arch Allergy Appl Immunol 1991;96:175-178.